WM's Q3 2026 Earnings: A Cash-Flow River Keeps flowing, and the EBITDA Keeps Growing Upstream

Key Takeaways at a Glance

• Revenue for the three months ended September 30, 2026: $6,846 million; compared with $6,443 million for the same period in 2025.
• Income from operations: $1,279 million in Q3 2026 vs $989 million in Q3 2025.
• Operating EBITDA: $2,071 million in Q3 2026; up from $1,753 million in Q3 2025. Adjusted EBITDA: $2,121 million in Q3 2026 vs $2,005 million in Q3 2025.
• Strong cash flow from operations supports a $957 million return to shareholders during the quarter.
• Healthcare Solutions increased income from operations by $41 million, driven by 3.7% revenue growth and cost improvements.
• The company presents both “As Reported” and “As Adjusted” metrics, with adjustments contributing meaningfully to EBITDA in prior periods.

What the numbers suggest about WM's operating engine

The quarter shows a disciplined performance: topline growth in line with a mid-single digit pace (3.7% in Healthcare Solutions), plus margin expansion as costs come under control. Operating EBITDA rising from $1.753 billion (2025) to $2.071 billion (2026) signals leverage on the revenue line, even if the absolute numbers aren’t iconic in isolation. The gap between “As Reported” and “As Adjusted” EBITDA in the current year—$2,071 versus $2,121—indicates the adjustments are helping to present a view of profitability that aligns better with operating reality, much like trimming the noise from a crowded recycling stream to reveal the value in the sorted materials.

Revenue remained robust, with $6.846 billion in the latest quarter versus $6.443 billion a year earlier. The company’s narrative around cash flow and capital returns is conspicuous. A $957 million cash return to shareholders in the quarter underscores WM’s capital-allocation discipline and the market’s tolerance for a company that prefers to reward owners rather than pile up non-core investments. In other words, the math isn’t just about the box score; it’s about how much cash is circulating back to investors while the business quietly improves its core profitability.

Earnings structure and the quiet contours of the quarter

Healthcare Solutions, a key segment, shows margin strength through both topline momentum and cost discipline. The reported increase in income from operations by $41 million reflects more than a one-off blip: it’s a signal that the mix within WM’s portfolio is contributing to a healthier operating cushion.

For investors who catechize earnings releases with EPS and earnings surprise, note that the SEC filing excerpt here highlights revenue and EBITDA metrics rather than a traditional single-line earnings-per-share figure. In practice, market participants will translate EBITDA and segment-level gains into an EPS proxy after adjusting for share count, potential tax effects, and any nonrecurring items. The presence of adjusted EBITDA alongside reported EBITDA invites a comparison to consensus expectations, even as the actual EPS and formal revenue forecast data are not embedded in the provided excerpt.

Implications for WM and sector peers

WM’s results reinforce a model where robust cash generation underpins a reliable capital-return cadence. For the sector, this is a reminder that the path to shareholder-friendly outcomes can coexist with organic growth and margin discipline. If WM continues to translate revenue growth into stronger operating leverage and a steady stream of cash returns, peers might feel pressure to accelerate share buybacks or increase dividend cadence to remain competitively priced from a total-return perspective.

From a competitive perspective, the combination of improved income from operations, higher EBITDA, and a meaningful cash return suggests WM is balancing growth with capital discipline—a formula some waste-management and environmental-services peers may try to emulate, especially if quarterly results keep reinforcing the link between segment mix, cost controls, and cash flow quality.

Context on EPS, earnings surprise, and revenue forecast

As is common in many press disclosures, the document presents revenue and EBITDA metrics rather than a clean EPS figure in the excerpt. In practice, analysts will map these results to an EPS estimate by accounting for shares outstanding and any non-operating items. The term earnings surprise—whether actual EPS exceeds consensus—will hinge on how WM’s adjusted results translate into per-share figures and how those figures compare with street estimates. Similarly, the revenue forecast and guidance for the next quarter or year will shape investors’ evolving EPS consensus as management reframes the path ahead. The absence of explicit EPS and guidance in the excerpt doesn’t erase the task for analysts; it simply shifts the work to the next public update and the usefulness of model-driven estimates.

Bottom line

WM’s Q3 2026 narrative centers on cash generation and margin discipline, with a meaningful capital-return story in the quarter. Revenue growth in Healthcare Solutions, combined with rising EBITDA and robust operating cash flow, paints a picture of a business that can fund returns while pursuing efficiency gains. For the sector, the takeaway is tangible: strong cash flow and a steady return of capital can coexist with revenue growth and margin expansion, potentially setting a benchmark for peers navigating a landscape of persistent cost pressures and competitive headwinds.

Investors and analysts will soon scrutinize EPS, earnings surprise, EPS consensus, and revenue forecast in relation to WM’s adjusted metrics and management's forward-looking commentary. Until then, the quarter’s headline—cash flow, EBITDA growth, and a generous shareholder-friendly stance—serves as a practical reminder that the math of capital allocation often travels the longer, quieter road to value.